Skip to main content
Professional Technical In the Industry Vocabulary Test

cytokine release syndrome

Pronunciation: SY-toh-kyne ree-LEES SIN-drome

Also written as: CRS — Cytokine Release Syndrome

A systemic inflammatory response characterized by fever and organ dysfunction, commonly associated with immunotherapies.

Full Definition

Cytokine release syndrome (CRS) is an acute systemic inflammatory syndrome characterized by fever and multiorgan dysfunction caused by excessive release of pro-inflammatory cytokines. It is a common toxicity of CAR-T cell therapy and other immunotherapies, occurring when activated immune cells release large quantities of cytokines including interleukin-6, interferon-gamma, and tumor necrosis factor-alpha. Symptoms range from mild flu-like illness to severe multiorgan failure requiring intensive care. Treatment includes supportive care and targeted therapies like tocilizumab (anti-IL-6 receptor antibody).

Usage

Usage note: Do not hyphenate 'cytokine release' but may hyphenate when used as compound modifier.

In Context

  • "Grade 2 cytokine release syndrome developed on day 3 after CAR-T cell infusion." — Progress note
  • "Tocilizumab was administered for management of severe cytokine release syndrome." — Treatment record

Also known as

CRS cytokine storm

Don't confuse with

tumor lysis syndrome sepsis

Editors from these organizations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON